VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT00369590
- Phase
- PHASE2
- Status
- Completed
Conditions
- Adult Anaplastic Astrocytoma
- Adult Anaplastic Oligodendroglioma
- Adult Giant Cell Glioblastoma
- Adult Gliosarcoma
- Recurrent Adult Brain Tumor
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- ziv-aflibercept — BIOLOGICALGiven IV
- pharmacological study — OTHERcorrelative studies
- laboratory biomarker analysis — OTHERcorrelative studies
Study Details
This phase II trial is studying how well VEGF Trap works in treating patients with recurrent malignant or anaplastic gliomas that did not respond to temozolomide. VEGF Trap may stop the growth of malignant or anaplastic gliomas by blocking blood flow to the tumor.
Key Dates
- Start date
- Aug 31, 2006
- Status verified
- Aug 2015
- Primary completion
- Dec 31, 2011
- Completion
- Oct 31, 2012
Study Design
- Enrollment
- 58 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: All Study PatientsPatients receive VEGF Trap (ziv-aflibercept) IV over 1 hour on day 1. Treatment repeats every 14 days in the absence of disease progression or unacceptable toxicity. Other: pharmacological study; laboratory biomarker analysis.
Primary Outcome Measure
Progression-free Survival (PFS) at 6 Months [ Time Frame: 6 months ]
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California Los Angeles | Los Angeles | California | 90095 | - |
| University of California San Francisco | San Francisco | California | 94115 | - |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | - |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | - |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15232 | - |
| M D Anderson Cancer Center | Houston | Texas | 77030 | - |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792 | - |
Find similar trials in Los Angeles, CA
Related Studies
- The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent GlioblastomaRecruiting · Erasmus Medical Center · San Francisco, California